The colorimetric fructosamine assay kit market is projected to grow from USD 298.2 million in 2026 to USD 433.0 million by 2036, at a CAGR of 3.8%. Plate reader kits will dominate with a 44.0% market share, while clinical diagnostic laboratories will lead the end‑user segment with a 45.0% share.